Evogene Schedules Third Quarter 2024 Financial Results Release

Rhea-AI Summary

Evogene (Nasdaq: EVGN, TASE: EVGN), a computational biology company, announced the release of its Q3 2024 financial results on November 21, 2024. The company's management will discuss the results in a Zoom conference call scheduled for the same day at 9:00 AM ET (4:00 PM Israel time). To attend, participants need to register in advance. The conference will be available online on Evogene's website a few days after the event.

Positive

• Evogene has scheduled a timely release of its Q3 2024 financial results, demonstrating transparency and commitment to keeping shareholders informed.

Negative

• None.

Zoom conference call scheduled for November 21, 2024, 9:00 AM ET

REHOVOT, Israel, Nov. 7, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the third quarter of 2024, on Thursday, November 21, 2024.

Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).

To join the conference, please register in advance:
https://us06web.zoom.us/webinar/register/WN_pG-Wc0JeQIifu1dmSUYOng

The entire conference will be available online on the company's website a few days after.

About Evogene:

Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.

Evogene established three unique tech-engines - MicroBoost AI, ChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).

Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its four subsidiaries including:

1. Biomica Ltd. (www.biomicamed.com) - developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI;
2. Lavie Bio Ltd. (www.lavie-bio.com) - developing and commercially advancing, microbiome-based ag-biologicals powered by MicroBoost AI;
3. AgPlenus Ltd. (www.agplenus.com) - developing next-generation ag chemicals for effective and sustainable crop protection powered by ChemPass AI;
4. Casterra Ag Ltd. (www.casterra.co) - developing and marketing superior castor seed varieties producing high yield and high-grade oil content on an industrial scale for the biofuel and other industries powered by GeneRator AI.

For more information, please visit: www.evogene.com.

Logo -  https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg

Contact
ir@evogene.com
Tel: +972-8-9311901

View original content:https://www.prnewswire.com/news-releases/evogene-schedules-third-quarter-2024-financial-results-release-302298582.html

SOURCE Evogene

FAQ

When will Evogene release its Q3 2024 financial results?

Evogene will release its Q3 2024 financial results on November 21, 2024.

What time is Evogene's Q3 2024 financial results conference call?

The conference call is scheduled for November 21, 2024, at 9:00 AM ET (4:00 PM Israel time).

How can I join Evogene's Q3 2024 financial results conference call?

You can join the conference call by registering in advance via the provided Zoom link.

Where can I access the recording of Evogene's Q3 2024 financial results conference call?

The recording will be available online on Evogene's website a few days after the conference.